Navigation Links
Alzheimer's drug market to hit $5.5 billion by 2009, study says

Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years.

Pharmaceutical manufacturers profiled in Millennium's study, entitled "Global Markets for Alzheimer's Disease Medications 2005," include Pfizer, Shire Pharmaceuticals and Novar......

Full article >>> Mithridion is hoping to be one of those companies in five to seven years, according to Johnson.

"There are a number of efforts to identify new approaches that actually treat the pathological process," Johnson noted. "That's in essence what we' re doing.

"We're right at the peak of the wave with this," he said. "It seems like the right time and the right place. We hopefully have a......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 05/16/05


Related biology technology :

1. Alzheimers drug developer lands $1.2M in venture funding
2. Biotech firm has strokes, Alzheimers in its sights
3. Mithridion wins grants for Alzheimers research
4. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Reforming FDA: Focus on safety, let market judge efficacy
10. Internet-enabled niche markets take center stage
11. GE Healthcare leads compact ultrasound market
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... HILL, N.C. , Feb. 5, 2016  In ... key role for a host of launch activities including ... importance of this launch activity is especially high in ... specialists. Best Practices and the Role of ... will help companies focused on oncology therapies find better ...
(Date:2/4/2016)... Massachusetts , February 4, 2016 - New FDA ... - New FDA action date of July 22, ... of July 22, 2016   - ... U.S. in the past decade indicated for the treatment of signs and symptoms ... Lifitegrast has the potential to be the only product approved in the U.S. ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):